.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers recently developed a novel approach using chloramphenicol transfersome delivery to treat eye infections. Specifically, they focused on applying these formulations directly onto the eyelid skin. Consequently, this method aims to bypass traditional ocular barriers. Furthermore, the study utilized transfersomes with an average size of 120 nm. Because these vesicles are monodispersed, they ensure uniform drug distribution. Moreover, this innovation could revolutionize how we manage bacterial conjunctivitis in clinical settings.
These ultra-deformable vesicles offer several clinical advantages. However, traditional eye drops often wash away quickly. In contrast, transfersomes penetrate the eyelid skin to reach the conjunctiva. Therefore, this system provides a sustained therapeutic effect. Additionally, the non-invasive nature improves patient compliance significantly. Ultimately, clinicians can expect better outcomes with reduced dosing frequency.
The skin of the eyelid acts as a gatekeeper for topical medications. Similarly, the unique composition of transfersomes allows them to squeeze through the stratum corneum. Hence, the drug reaches the infection site without direct irritation to the eyeball. Notably, this method reduces systemic side effects by focusing on local delivery. As a result, it provides a safer alternative for sensitive populations like children.
Transfersomes contain edge activators that make them ultra-deformable. Consequently, they can squeeze through tiny pores in the skin more effectively than rigid liposomes. This enhances drug penetration significantly.
Eyelid application allows the drug to penetrate the skin and reach the conjunctiva locally. Therefore, it reduces the discomfort and rapid drainage issues associated with traditional eye drops. This ensures a higher concentration of the drug stays at the target site.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Grygor'yeva L et al. Chloramphenicol Application Onto the Eyelid: Transfersomes for Enhanced Skin Delivery. AAPS PharmSciTech. 2026 Jun 11. doi: undefined. PMID: 42277546.
Vyavahare SS, et al. Chloramphenicol Overview in Eye Infections. International Journal of Pharmacy & Pharmaceutical Research. 2024; 30(5): 72-84.
Dua A, et al. Transfersomes: A Vesicular Tool for Transdermal Drug Delivery. Innovative Lipid-Based Vesicles. 2026.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers have developed chloramphenicol-loaded transfersomes (120 nm) to treat conjunctivitis via eyelid application. This novel delivery system enhances drug permeability and stability, offering a promising non-invasive alternative to traditional eye drops for managing ocular infections.
4 months ago
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
